Should atropine be administered prophylactically before every pediatric endotracheal intubation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Atropine is NOT routinely given before every pediatric intubation

Based on the most recent 2025 AHA/AAP guidelines, atropine use as premedication for pediatric emergency intubation is optional and should be reserved for select high-risk situations, not administered universally. 1

Current Guideline Recommendation

The 2025 American Heart Association and American Academy of Pediatrics guidelines provide a Class 2b recommendation (weak) stating that "it may be reasonable to use atropine as a premedication to prevent bradycardia in infants and children during emergency intubation" 1. This represents a significant shift from older practices that advocated more routine use.

Key Points from the Guidelines:

  • No survival benefit demonstrated: There is no evidence that preintubation atropine improves survival or prevents cardiac arrest in pediatric patients 1
  • Mixed evidence on bradycardia prevention: While two prospective observational studies from 2007-2009 showed associations with decreased ICU mortality and reduced bradycardia, four retrospective studies found no association between atropine use and bradycardia occurrence 1
  • Limited evidence quality: The recommendation is based on low-quality observational data (Level of Evidence: C-LD) 1

When to Consider Atropine Use

Atropine may be reasonable in specific high-risk scenarios:

  • Infants and young children (particularly those under 8 years old, especially infants who are most susceptible to vagally-mediated bradycardia) 1, 2
  • When using succinylcholine as the neuromuscular blocker 3
  • Septic shock or hypovolemia where bradycardia could precipitate hemodynamic collapse 2
  • Patients aged 28 days to 8 years in PICU settings with cardiovascular instability 2

Dosing When Used

If atropine is administered, the 2025 guidelines recommend:

  • Dose: 0.02 mg/kg with no minimum dose 1
  • This eliminates the historical 0.1 mg minimum dose requirement, which was based on weak evidence from a 1971 study 1

Evolution of Practice

This represents a reversal from older dogma:

  • 2015 AHA Guidelines: Already stated that "available evidence does not support the routine use of atropine preintubation" but allowed for selective use 3
  • 2025 Guidelines: Further weakened the recommendation to "may be reasonable" (Class 2b) rather than mandatory 1
  • The shift reflects recognition that previous guidelines discouraged routine administration and that evidence supporting universal use is lacking 1

Supporting Evidence Against Routine Use

Recent research challenges routine atropine administration:

  • A 2023 observational study found atropine did not prevent hypoxemia or bradycardia during pediatric emergency department intubations; paradoxically, atropine was associated with higher odds of bradycardia in multivariable analysis 4
  • A 2022 study showed low bradycardia incidence (4.8%) regardless of atropine use, with similar rates between atropine and non-atropine groups 5
  • Multiple studies demonstrate that bradycardia during pediatric intubation is less common than historically believed 5, 6, 7

Clinical Algorithm

Assess the clinical scenario:

  1. Emergency intubation in stable patient without high-risk features → Atropine NOT routinely needed
  2. Infant (<1 year) or young child (<8 years) with:
    • Septic shock/hypovolemia, OR
    • Plan to use succinylcholine, OR
    • Cardiovascular instability → Consider atropine 0.02 mg/kg IV
  3. Older child (>8 years) with stable hemodynamics → Atropine generally NOT indicated

Important Caveats

  • Atropine does not prevent all bradycardia: Some patients will experience bradycardia regardless of pretreatment 6
  • Hypoxemia and adequate ventilation are the priority: Oxygenation and ventilation are essential first maneuvers; epinephrine is the drug of choice if bradycardia persists despite adequate oxygenation 1
  • Multiple causes of peri-intubation bradycardia exist: Including hypoxemia, underlying disease, medications (succinylcholine, fentanyl), transition to positive pressure ventilation, and vagal stimulation 1
  • No minimum dose required: The historical 0.1 mg minimum to prevent "paradoxical bradycardia" is no longer supported 1

Bottom Line

Atropine should NOT be given routinely before every pediatric intubation. Its use should be selective, reserved for high-risk situations involving young infants, hemodynamically unstable patients, or when using succinylcholine. The focus should remain on optimizing oxygenation and ventilation as the primary interventions to prevent bradycardia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.